Where does Rani Therapeutics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rani Therapeutics, LLC ranks #4,130 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rani Therapeutics, LLC hold?

Rani Therapeutics, LLC holds 87 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Rani Therapeutics, LLC's Innovation Score?

Rani Therapeutics, LLC has an Innovation Score of 46.0 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rani Therapeutics, LLC focus on?

Rani Therapeutics, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 84 patents, ranking #229 of 7,163 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Rani Therapeutics, LLC's patent grant rate increasing or decreasing?

Rani Therapeutics, LLC's recent grant velocity is +2% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Rani Therapeutics, LLC's patents?

Rani Therapeutics, LLC's patents average 24.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rani Therapeutics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rani Therapeutics, LLC

USPTO PatentsView assignee record - 87 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rani ranks #4,130 of 49,997 tracked US assignees by granted-patent volume, with 87 patents across 8 technology areas.

#4,130
of 49,997 US assignees by volume: Top 22%
by Innovation Score (46.0/100): 24.6
avg claims per patent: +2%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4130 · US Corporation #4,130 · 87 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 87 grants
TOP-DECILE #4,130/49,997
PHOTO-FINISH Nuscale Power
CPC-NARROW A61K · 8 areas
INNOV-PAR 46.0/100
CLAIMS-DENSE 24.6 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +2% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nuscale Power, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rani’s 46.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.5 pts (34%) Velocity 5.7 pts (12%) Breadth 10.0 pts (22%) Claim depth 14.7 pts (32%)

Qualcomm Incorporated · highest

85
B-K Medical APS · near

46
Lund Motion Products · near

46
Rani Therapeutics · this assignee

46
Wm Wrigley Jr · near

46
Future Motion · near

46
3D Lighting… · lowest

7

What this shows Rani's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rani?

Each dot is one of Rani’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rani’s own 24.6 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rani vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rani's grants concentrate

Rani Therapeutics, LLC is a focused PatentsView assignee: 8 CPC subclasses with 96.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (14 grants) versus a trough of 2 in 2024. By volume, Rani sits between Nuscale Power, LLC and Sensirion AG.

Rani's three-year grant acceleration

From 2019–2021 to 2022–2024, Rani Therapeutics, LLC moved from 29 to 25 grants (0.86x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Nuscale Power

87
Objectvideo Labs

87
Orbital ATK

87
Panasonic Energy

87
Sumitomo Electric…

87
Sumitomo Electric…

87
Suzhou Lekin Semi…

87
Sensirion

87
Rani Therapeutics ◀

87

What this shows Rani holds 87 patents at rank #4,130, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rani

By rank, the assignees closest to #4,130 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Rani's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rani, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Rani ranks #229 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Wm. Wrigley Jr. Company 46 B-K Medical APS 46 Lund Motion Products, Inc. 46 Future Motion, Inc. 46

Similar claim depth

Nearest assignees by average claims per patent (24.6 here).

Restoration Robotics, Inc. 24.6 avg VMI Holland B.V. 24.6 avg Flexiworld Technologies, Inc. 24.6 avg Tula eTechnology, Inc. 24.5 avg

Rani's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rani Therapeutics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	4.6%
2016	12	13.8%
2017	7	8.0%
2018	6	6.9%
2019	12	13.8%
2020	9	10.3%
2021	8	9.2%
2022	9	10.3%
2023	14	16.1%
2024	2	2.3%
2025partial year	4	4.6%

Which technologies does Rani Therapeutics, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 84

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 79

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

C07K - Peptides 26

A61B - DIAGNOSIS; SURGERY; Identification 10

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rani Therapeutics, LLC's patent record in context - here's where to go next.

Rani Therapeutics, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #4,130 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rani Therapeutics, LLC against Nuscale Power, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.